Skip to main content
Clinical Trials/NCT04759183
NCT04759183
Completed
Not Applicable

Impact of Different Virtual Reality Experiences on Anxiety and Pain

OHSU Knight Cancer Institute1 site in 1 country32 target enrollmentMarch 5, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hematopoietic and Lymphoid Cell Neoplasm
Sponsor
OHSU Knight Cancer Institute
Enrollment
32
Locations
1
Primary Endpoint
Change in postoperative pain scores
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

This trial studies the impact of virtual reality experiences on anxiety before surgery and pain after surgery. The goal of this study is to examine how different virtual reality experiences may help reduce anxiety and improve pain control, which may help reduce the need for medications such as opioids.

Detailed Description

PRIMARY OBJECTIVE: I. To measure the impact of a gaming virtual reality (VR) experience compared to a mindfulness VR experience on preoperative anxiety and postoperative pain. OUTLINE: Patients are randomized to 1 of 2 arms. ARM I: Patients participate in a VR intervention (Angry Birds) over 15 minutes before standard of care surgery and then participate in a VR intervention (TRIPP) over 15 minutes after surgery. ARM II: Patients participate in a VR intervention (TRIPP) over 15 minutes before standard of care surgery and then participate in a VR intervention (Angry Birds) over 15 minutes after surgery.

Registry
clinicaltrials.gov
Start Date
March 5, 2021
End Date
August 25, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ryan Li, MD

Principal Investigator

OHSU Knight Cancer Institute

Eligibility Criteria

Inclusion Criteria

  • Adults (18 years or older and younger than 89)
  • Able to consent
  • English-speaking

Exclusion Criteria

  • Non-English speaking patients because the VR content is only available in English
  • Have symptoms concerning for an active respiratory infection or are on contact or isolation precautions
  • Any active eye discharge
  • A history of seizure, epilepsy, or hypersensitivity to flashing light
  • Have a history of motion sickness or vertigo
  • Have active nausea or vomiting
  • Psychiatric conditions that may interfere with the ability to successfully participate in the study
  • Have cardiac pacemakers
  • Require hearing aids at all times that cannot be removed
  • Have defibrillators

Outcomes

Primary Outcomes

Change in postoperative pain scores

Time Frame: Baseline after surgery up to study completion (estimated 1 day)

Assessed by VAS scale from 0-100mm.

Change in preoperative anxiety scores

Time Frame: Baseline up to pre surgery (estimated 1 day)

Assessed by visual analogue scale (VAS) from 0-100mm.

Secondary Outcomes

  • Change in blood pressure(immediately before intervention, and then immediately after intervention (estimated 1 day))
  • Patient enjoyment of each VR experience(Up to study completion (estimated 1 day))
  • Change in heart rate(immediately before intervention, and then immediately after intervention (estimated 1 day))
  • Patient desire to use VR more in their healthcare(Up to study completion (estimated 1 day))

Study Sites (1)

Loading locations...

Similar Trials